cannabis indica

Índice completo — página 61 de 77

Estudos 6.001 a 6.100 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2013 a 2012. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 6.001 a 6.100

  1. 2013

    Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and “Triptan” Receptors: Implications in Migraine

    FavorávelEstudo em AnimaisEnxaquecaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+4
  2. 2013

    Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults

  3. 2013

    Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study

  4. 2013

    Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats

    FavorávelEstudo em AnimaisNáusea e VômitoTetraidrocanabivarina (THCV)Canabidivarina (CBDV)
  5. 2013

    Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma

    FavorávelEstudo LaboratorialCâncerCâncer — LinfomaCanabinoides Sintéticos AM-x
  6. 2013

    Fat to treat fat: Emerging relationship between dietary PUFA, endocannabinoids, and obesity

    FavorávelMetanáliseObesidadeSíndrome MetabólicaDieta
  7. 2013

    Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator

  8. 2013

    H-FABP, cardiovascular risk factors, and functional status in asymptomatic spinal cord injury patients

  9. 2013

    Human breast tissue disposition and bioactivity of limonene in women with early stage breast cancer.

    FavorávelEnsaio ClínicoCâncerCâncer — Mama
  10. 2013

    Illicit drug use among pregnant women enrolled in treatment for cigarette smoking cessation

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Opioides+5
  11. 2013

    Impact of omega-6 polyunsaturated fatty acid supplementation and γ-aminobutyric acid on astrogliogenesis through the endocannabinoid system

    FavorávelEstudo LaboratorialAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+3
  12. 2013

    Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia

    DesfavorávelEnsaio ClínicoDepressãoPsicoseEsquizofreniaEndocanabinoide (não especificado)
  13. 2013

    Influence of ethanol on the pharmacokinetic properties of Δ9-tetrahydrocannabinol in oral fluid

  14. 2013

    Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut.

  15. 2013

    Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception.

    FavorávelEstudo em AnimaisDorCanabinoides Sintéticos AM-x
  16. 2013

    Ischemic stroke after use of the synthetic marijuana “spice”

  17. 2013

    K2 Toxicity: Fatal Case of Psychiatric Complications Following AM2201 Exposure†

  18. 2013

    Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson’s disease in the rat

    FavorávelEstudo em AnimaisDoença de Parkinson
  19. 2013

    Low Dose Vaporized Cannabis Significantly Improves Neuropathic Pain.

  20. 2013

    Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV–Hepatitis C Coinfection: A Longitudinal Cohort Analysis.

    InconclusivoMetanáliseHIV/AIDSFibroseHepatite+1
  21. 2013

    Marijuana use and long-term mortality among survivors of acute myocardial infarction

    FavorávelMetanáliseDoenças Cardiovasculares (DCV)Infarto
  22. 2013

    Marijuana Use Is Associated With Inattention In Men And Sleep Quality In Women With Attention-Deficit/Hyperactivity Disorder: A Preliminary Study

    FavorávelMetanáliseTDA e TDAH
  23. 2013

    Marijuana's dose-dependent effects in daily marijuana smokers

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)Tetraidrocanabinol (THC)
  24. 2013

    Measurement of palmitoylethanolamide and other N-acylethanolamines during physiological and pathological conditions

  25. 2013

    Metabolic effects of chronic cannabis smoking

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)Diabetes+3
  26. 2013

    Modulation of 3,4-methylenedioxymethamphetamine effects by endocannabinoid system

  27. 2013

    Mouse Models for Studying Pain In Sickle Disease: Effects of Strain, Age, and Acuteness

  28. 2013

    Non-THC Cannabinoids Inhibit Prostate Carcinoma Growth In Vitro And In Vivo: Pro-apoptotic Effects And Underlying Mechanisms

    FavorávelEstudo em AnimaisCâncerCâncer — PróstataCanabigerol (CBG)Canabinol (CBN)+5
  29. 2013

    Oral administration of d-limonene controls inflammation in rat colitis and displays anti-inflammatory properties as diet supplementation in humans.

  30. 2013

    Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy

  31. 2013

    Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries

  32. 2013

    Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma

  33. 2013

    Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain

    FavorávelMetanáliseDorInflamaçãoDor — CrônicaPalmitoiletanolamida (PEA)+1
  34. 2013

    Perillyl Alcohol as a Protective Modulator Against Rat Hepatocarcinogenesis via Amelioration of Oxidative Damage and Cell Proliferation

    FavorávelEstudo em AnimaisCâncerEstresse OxidativoCâncer — Fígado
  35. 2013

    Physical and Psychologic Effects of Aromatherapy Inhalation on Pregnant Women: A Randomized Controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoGestação
  36. 2013

    Preventive and ameliorating effects of citrus D-limonene on dyslipidemia and hyperglycemia in mice with high-fat diet-induced obesity

    FavorávelEstudo em AnimaisObesidadeDiabetesSíndrome Metabólica
  37. 2013

    Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract

    FavorávelEstudo em AnimaisDII — Doença Inflamatória IntestinalÚlcera Gástrica
  38. 2013

    Proof of Concept Trial of Dronabinol in Obstructive Sleep Apnea.

    FavorávelEnsaio ClínicoApneia do SonoTetraidrocanabinol (THC)
  39. 2013

    Prospects for cannabinoid therapies in viral encephalitis.

  40. 2013

    Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE)

  41. 2013

    Reductions in Circulating Endocannabinoid Levels in Individuals with Post-Traumatic Stress Disorder Following Exposure to the World Trade Center Attacks

    FavorávelEnsaio ClínicoAnsiedadeTEPTAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  42. 2013

    Remote ischemic pre-conditioning alleviates contrast-induced acute kidney injury in patients with moderate chronic kidney disease

  43. 2013

    Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1–Mediated Antinociceptive and Gastroprotective Effects

  44. 2013

    Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.

  45. 2013

    Risking the skin for some joints

    DesfavorávelMetanáliseAlergia à Cannabis
  46. 2013

    Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat

  47. 2013

    Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  48. 2013

    Study on the anti-cerebral ischemia effect of borneol and its mechanism

    FavorávelEstudo em AnimaisAVC
  49. 2013

    Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisAnsiedadeDoenças Cardiovasculares (DCV)+8
  50. 2013

    Synergistic Effect of Lupenone and Caryophyllene Oxide against Trypanosoma cruzi.

    FavorávelEstudo em AnimaisDoença de Chagas
  51. 2013

    Synthetic cannabinoid overdose in a 20-year-old male US soldier

  52. 2013

    Targeting the Endocannabinoid System in the Treatment of Fragile X Syndrome

    FavorávelEstudo em AnimaisSíndrome do X Frágil
  53. 2013

    Targeting the Endocannabinoid System to Treat Sepsis.

    FavorávelMetanáliseSepseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+4
  54. 2013

    Terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis

    FavorávelMetanáliseCálculos Renais
  55. 2013

    Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.

  56. 2013

    Th1 and Th2 cytokine gene expression in primary infection and vaccination against Fasciola gigantica in buffaloes by real-time PCR

  57. 2013

    The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55

    InconclusivoEstudo LaboratorialEndocanabinoide (não especificado)Lisofosfatidilinositol (LPI)
  58. 2013

    The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity.

  59. 2013

    The combination of oral L-DOPA/rimonabant for effective dyskinesia treatment and cytological preservation in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia

    FavorávelEstudo em AnimaisDoença de ParkinsonCanabinoides Sintéticos SR-x
  60. 2013

    The endocannabinoid system and emotional processing: a pharmacological fMRI study with ∆9-tetrahydrocannabinol

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoTetraidrocanabinol (THC)
  61. 2013

    The endocannabinoid system and the brain

  62. 2013

    The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD).

  63. 2013

    The Gastric CB1 Receptor Modulates Ghrelin Production through the mTOR Pathway to Regulate Food Intake.

    FavorávelEstudo em AnimaisObesidadeAnorexia (perda de apetite)Canabinoides Sintéticos SR-x
  64. 2013

    The impact of marijuana use on glucose, insulin, and insulin resistance among US adults.

    FavorávelMetanáliseObesidadeDiabetesSíndrome Metabólica
  65. 2013

    The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care

    FavorávelMetanáliseCuidados Paliativos
  66. 2013

    The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.

  67. 2013

    The pathophysiology and pharmacological treatment of Huntington disease

    DesfavorávelMetanálise ClínicaDoenças Cardiovasculares (DCV)Doença de Huntington
  68. 2013

    The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action

    FavorávelEstudo em AnimaisCâncerTetraidrocanabinol (THC)
  69. 2013

    The sedative effect of inhaled terpinolene in mice and its structure-activity relationships.

    FavorávelEstudo em AnimaisAnsiedade
  70. 2013

    The synthetic cannabinoid withdrawal syndrome

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  71. 2013

    The use of cannabinoids in chronic pain

    FavorávelMetanáliseDorCâncerDor — CrônicaTHC Farmacêutico
  72. 2013

    The Volitional Nature Of Nicotine Exposure Alters Anandamide And Oleoylethanolamide Levels In The Ventral Tegmental Area

  73. 2013

    Towards a better cannabis drug

  74. 2013

    Trans-β-Caryophyllene: An Effective Antileishmanial Compound Found in Commercial Copaiba Oil (Copaifera spp.)

    FavorávelEstudo LaboratorialLeishmaniose
  75. 2013

    Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents.

    FavorávelEstudo LaboratorialCâncerCâncer — Cérebro
  76. 2013

    Two novel mutations in ABHD12: expansion of the mutation spectrum in PHARC and assessment of their functional effects.

  77. 2013

    Understanding the molecular aspects of tetrahydrocannabinol and cannabidiol as antioxidants

    FavorávelEstudo LaboratorialDorEstresse OxidativoDor — NociceptivaTetraidrocanabinol (THC)
  78. 2013

    Use of cannabis among 139 cluster headache sufferers

    FavorávelMetanáliseEnxaqueca
  79. 2013

    Weed or Wheel! fMRI, Behavioural, and Toxicological Investigations of How Cannabis Smoking Affects Skills Necessary for Driving

    DesfavorávelEnsaio ClínicoEfeitos Adversos da Cannabis
  80. 2013

    α-Terpineol Induces Fatty Liver in Mice Mediated by the AMP-activated Kinase and Sterol Response Element Binding Protein Pathway

    DesfavorávelEstudo LaboratorialEsteatose Hepática
  81. 2013

    β-caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.

    FavorávelEstudo em AnimaisNefropatia Induzida por Medicamentos
  82. 2013

    Δ9-Tetrahydrocannabinol Impairs the Inflammatory Response to Influenza Infection: Role of Antigen-Presenting Cells and the Cannabinoid Receptors 1 and 2

    DesfavorávelEstudo em AnimaisGripeTetraidrocanabinol (THC)
  83. 2012

    "Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans

  84. 2012

    [Six-month follow-up study of drug treatment for cannabis addiction: comparison study of four drugs]

  85. 2012

    ∆(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells

    InconclusivoEstudo LaboratorialCâncerCâncer — NeuroblastomaDor — Nociceptiva
  86. 2012

    A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury

  87. 2012

    A case of self amputation of penis by cannabis induced psychosis

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  88. 2012

    A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — CrônicaEsclerose MúltiplaTHC:CBD Farmacêutico+2
  89. 2012

    A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+2
  90. 2012

    A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men

    FavorávelEnsaio Clínico Duplo-CegoDiabetesSíndrome MetabólicaAnorexia (perda de apetite)Tetraidrocanabinol (THC)+1
  91. 2012

    A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid

  92. 2012

    A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — Cannabis
  93. 2012

    A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity

    DesfavorávelMetanálise ClínicaObesidadeCanabinoides Sintéticos SR-x
  94. 2012

    Activation of Cannabinoid Receptor 2 Attenuates Leukocyte–Endothelial Cell Interactions and Blood–Brain Barrier Dysfunction under Inflammatory Conditions

    FavorávelEstudo LaboratorialInflamaçãoCanabinoides Sintéticos JWH-xCanabinoides Sintéticos O-x
  95. 2012

    Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis

    DesfavorávelMetanálise ClínicaEfeitos Adversos da Cannabis
  96. 2012

    Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisAnsiedadePsicose
  97. 2012

    Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong

  98. 2012

    Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans

  99. 2012

    Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria

  100. 2012

    Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system.

    FavorávelEstudo LaboratorialEsclerose SistêmicaCanabinoides Sintéticos WIN-x